Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Cash from Investing Activities: 2013-2023

Historic Cash from Investing Activities for vTv Therapeutics (VTVT) over the last 9 years, with Dec 2023 value amounting to $4.4 million.

  • vTv Therapeutics' Cash from Investing Activities was N/A to $4.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2023, which is 21071.43% up from last year.
  • Latest data reveals that vTv Therapeutics reported Cash from Investing Activities of $4.4 million as of FY2023, which was up 21,071.43% from -$21,000 recorded in FY2022.
  • In the past 5 years, vTv Therapeutics' Cash from Investing Activities registered a high of $4.4 million during FY2023, and its lowest value of -$21,000 during FY2022.
  • For the 2-year period, vTv Therapeutics' Cash from Investing Activities averaged around $2.2 million, with its median value being $2.2 million (2022).
  • Data for vTv Therapeutics' Cash from Investing Activities shows a peak YoY skyrocketed of 21,071.43% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows vTv Therapeutics' Cash from Investing Activities stood at $242,000 in 2019, then reached -$21,000 in 2022, then soared by 21,071.43% to $4.4 million in 2023.